IPO flood­gates open up af­ter sum­mer lull as five more biotechs file for Nas­daq

It’s once again open sea­son for biotech IPOs, as the sum­mer drought has giv­en way to an au­tumn flood.

Five com­pa­nies filed to go pub­lic on Fri­day, in­clud­ing four pen­cil­ing in $100 mil­lion fundrais­es: Evotec, En­tra­da Ther­a­peu­tics, Au­ra Bio­sciences and Vaxxin­i­ty. The fifth biotech, Blue Wa­ter Vac­cines, is es­ti­mat­ing a more mod­est $24 mil­lion.

The com­bined in­dus­try raise sur­passed $14 bil­lion last week af­ter two more biotechs priced, per the End­points News tal­ly, and the sec­tor re­mains on pace to eclipse last year’s record of $16.5 bil­lion. It could come down to the wire, how­ev­er, af­ter a third quar­ter lull that saw the low­est lev­els of IPO num­bers since the start of 2020.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER